Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 07/28/21
End: 12/31/25
Due: 12/31/26
Phase: N/A
Priority: Normal
Start: 12/30/19
End: 04/30/22
Due: 04/30/23
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| PaTHway CHINA TRIAL: A Trial to Investigating the Safety, Tolerability and Efficacy of TransCon PTH in Adults With Hypoparathyroidism | NCT05387070 | Visen Pharmaceuticals (Shanghai) Co., Ltd. | user2@example.com | None | 2021-07-28 | 2025-12-31 | 2026-12-31 | - | - | 2025-07-14 |
| Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Chinese Pediatric Growth Hormone Deficiency | NCT04326374 | Visen Pharmaceuticals (Shanghai) Co., Ltd. | user2@example.com | None | 2019-12-30 | 2022-04-30 | 2023-04-30 | - | - | 2025-07-14 |